PUMA BIOTECHNOLOGY, INC. 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Apr 18, 2016
Insider Transaction Report
Form 4
PHILLIPS RICHARD BENTON
Sr VP Reg Affairs & QA
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2016-04-15+25,000→ 25,000 totalExercise: $31.85Exp: 2026-04-14→ COMMON STOCK (25,000 underlying)
Footnotes (1)
- [F1]The vesting commencement date ("VCD") of the option is April 15, 2016. 100% of the shares of common stock underlying the option shall vest on the earlier of (i) the one-year anniversary of the VCD and (ii) the date on which a new Head of Regulatory Affairs commences employment with the Issuer, subject to the Reporting Person's continued employment with the Issuer through the vesting date.